Iron Deficiency with Depleted Iron Stores
Your patient has absolute iron deficiency with depleted iron stores, confirmed by a transferrin saturation of 13% (below the diagnostic threshold of 16%) and an elevated TIBC of 409 µg/dL. 1
Diagnostic Interpretation
Your iron panel demonstrates the classic pattern of iron deficiency:
- Transferrin saturation 13% is below the diagnostic cutoff of 16% for iron deficiency in adults, confirming true deficiency 1
- Elevated TIBC (409 µg/dL) reflects the body's compensatory attempt to maximize iron-binding capacity when iron stores are depleted 1
- Elevated UIBC (355 µg/dL) indicates a high proportion of vacant iron-binding sites on transferrin, which is a more accurate marker for empty iron stores than serum iron alone (diagnostic accuracy 0.80-0.97) 1
- Low serum iron (54 µg/dL) combined with these findings confirms absolute iron deficiency 1
The mathematical relationship confirms internal consistency: TIBC = serum iron + UIBC (409 = 54 + 355) 1
Mandatory Next Steps
1. Complete the Iron Panel
Obtain serum ferritin immediately to quantify iron stores and guide treatment targets 1:
- In the absence of inflammation (verify with C-reactive protein), ferritin <30 µg/L definitively establishes iron deficiency 1
- Ferritin <100 ng/mL confirms absolute iron deficiency requiring treatment 1
- Critical caveat: Ferritin is an acute-phase reactant and can be falsely elevated during illness, inflammation, or stress, potentially masking iron deficiency 1
Obtain complete blood count with hemoglobin, hematocrit, MCV, and reticulocyte count to assess the severity of anemia and bone marrow response 1
Measure C-reactive protein to assess for inflammation, which affects interpretation of ferritin levels 2, 1
2. Identify the Underlying Cause
Iron deficiency mandates a search for the underlying source, as it rarely occurs without identifiable loss or inadequate intake 1:
- Screen for gastrointestinal bleeding with fecal occult blood testing; if positive, endoscopic evaluation (colonoscopy first if age >50) is required 1, 3
- Assess menstrual blood loss in premenopausal women as a primary cause 1
- Evaluate for malabsorption disorders including celiac disease and inflammatory bowel disease 1
- Review medications for NSAID use, which commonly causes occult GI bleeding 1
- Consider dietary insufficiency, restrictive diets, blood donation, or high-impact athletic activity causing hemolysis 1
Calculate estimated glomerular filtration rate using age, gender, race, and serum creatinine to assess for chronic kidney disease (CKD stages 2-3), as CKD alters iron metabolism and treatment approach 1
3. Treatment Strategy
Initiate oral iron supplementation as first-line therapy unless contraindications exist 1:
- Therapeutic targets: Achieve ferritin ≥100 ng/mL and transferrin saturation ≥20% 1
- Reassess hemoglobin at 4 weeks: Expect a 1-2 g/dL increase if treatment is effective 3
- If no response after 4-8 weeks, consider malabsorption, continued bleeding, or switch to intravenous iron 1
Consider intravenous iron in specific circumstances 1:
- Gastrointestinal intolerance to oral iron
- CKD with eGFR <30 mL/min/1.73 m²
- Lack of hematologic response after adequate oral iron trial
Common Pitfalls to Avoid
- Do not dismiss iron deficiency based on "normal" serum iron alone, as serum iron exhibits high day-to-day variability and is influenced by recent meals, diurnal changes, and inflammation 1
- Do not assume normal ferritin excludes iron deficiency if inflammation is present; use the higher threshold of 100 µg/L in inflammatory states 2, 1
- Do not overlook gastrointestinal malignancy: 9% of patients older than 65 years with iron deficiency anemia have GI cancer when evaluated 3
- Do not stop at treating the anemia—failure to identify the underlying cause (especially occult bleeding) can lead to serious missed diagnoses 1, 3